Recent Analyst Forecasts and Stock Ratings
Xilio Therapeutics Inc FAQ's
Xilio Therapeutics Inc has been rated by research analysts at Raymond James, Chardan Capital in the past 90 days.
Xilio Therapeutics Inc has been rated by research analysts at Raymond James, Chardan Capital in the past 90 days.